These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7174671)

  • 21. Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and heparin.
    Blaskó G
    Prostaglandins; 1979 Jul; 18(1):3-9. PubMed ID: 160589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of heparin on the extent of inhibition of thrombin by heparin cofactor.
    Owen WG
    Biochim Biophys Acta; 1977 Sep; 494(1):182-90. PubMed ID: 71165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of thrombin to thrombomodulin accelerates inhibition of the enzyme by antithrombin III. Evidence for a heparin-independent mechanism.
    Preissner KT; Delvos U; Müller-Berghaus G
    Biochemistry; 1987 May; 26(9):2521-8. PubMed ID: 3038185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reaction of antithrombin with proteases. Evidence for a specific reaction with papain.
    Valeri AM; Wilson SM; Feinman RD
    Biochim Biophys Acta; 1980 Aug; 614(2):526-33. PubMed ID: 7407200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered inactivation of trinitrophenylated thrombin by antithrombin III in the presence of heparin.
    Machovich R; Regoeczi E; Hatton MW
    Thromb Res; 1980 Feb 1-15; 17(3-4):383-91. PubMed ID: 6768161
    [No Abstract]   [Full Text] [Related]  

  • 26. Kinetic analysis of the heparin-enhanced antithrombin III/thrombin reaction. Reaction rate enhancement by heparin-thrombin association.
    Griffith MJ
    J Biol Chem; 1979 Dec; 254(23):12044-9. PubMed ID: 500693
    [No Abstract]   [Full Text] [Related]  

  • 27. Kinetics of heparin action.
    Shore JD; Olson ST; Craig PA; Choay J; Björk I
    Ann N Y Acad Sci; 1989; 556():75-80. PubMed ID: 2786689
    [No Abstract]   [Full Text] [Related]  

  • 28. Heparin-like tubings. III. Kinetics and mechanism of thrombin, antithrombin III and thrombin-antithrombin complex adsorption under controlled-flow conditions.
    Migonney V; Fougnot C; Jozefowicz M
    Biomaterials; 1988 Sep; 9(5):413-8. PubMed ID: 3224126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic inhibition by antithrombin III and heparin-like compounds of thrombin-induced platelet aggregation [proceedings].
    Kindness G; Williamson FB; Long WF
    Biochem Soc Trans; 1980 Feb; 8(1):85-6. PubMed ID: 6154614
    [No Abstract]   [Full Text] [Related]  

  • 30. Anticoagulating and non-enzymatic fibrinolytic activities of heparin-antithrombin III and antithrombin III-heparin-thrombin complexes in vitro and in vivo.
    Kudrjashov BA; Pastorova VE; Lyapina LA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):731-42. PubMed ID: 6198257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kinetics of the heparin-enhanced antithrombin III/thrombin reaction. Evidence for a template model for the mechanism of action of heparin.
    Griffith MJ
    J Biol Chem; 1982 Jul; 257(13):7360-5. PubMed ID: 7085630
    [No Abstract]   [Full Text] [Related]  

  • 32. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III.
    Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT
    Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B; Brieditis I; Bock SC; Olson ST; Björk I
    Biochemistry; 1997 Jun; 36(22):6682-91. PubMed ID: 9184148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of NaC1 on inactivation of bovine thrombin by antithrombin III in the presence of low affinity-heparin or dextran sulfate.
    Oshima G; Nagasawa K
    Thromb Res; 1986 Feb; 41(3):361-72. PubMed ID: 2422780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
    Holmer E; Kurachi K; Söderström G
    Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of surface charge on the accelerating action of heparin on the antithrombin III-inhibited activity of alpha-thrombin.
    Heuck CC; Schiele U; Horn D; Fronda D; Ritz E
    J Biol Chem; 1985 Apr; 260(8):4598-603. PubMed ID: 3988727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reaction of thrombins with human antithrombin III: II. Dependence of rate of inhibition on molecular form and origin of thrombin.
    Latallo ZS; Jackson CM
    Thromb Res; 1986 Sep; 43(5):523-37. PubMed ID: 3755846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The catalysis by heparin of the reaction between thrombin and antithrombin.
    Evington JR; Feldman PA; Luscombe M; Holbrook JJ
    Biochim Biophys Acta; 1986 Mar; 870(1):92-101. PubMed ID: 3947650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of potentiation of antithrombin III and heparin cofactor II inhibition by sulfated xylans.
    Carson L; Doctor VM
    Thromb Res; 1990 May; 58(4):367-81. PubMed ID: 1972302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin.
    Lawson JH; Butenas S; Ribarik N; Mann KG
    J Biol Chem; 1993 Jan; 268(2):767-70. PubMed ID: 8419351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.